Clinical Laboratory Trends
Clinical laboratories, where tests are done on clinical specimens in order to get information about the health of a patient as pertaining to the diagnosis, treatment, and prevention of disease, are facing numerous challenging trends as healthcare reform continues to evolve.
Some of these clinical laboratory trends include:
- The Protecting Access to Medicare Act (PAMA) of 2014.
Under PAMA, many clinical lab organizations will see a substantial decline over the coming years in the prices paid to them for the highest-volume lab tests reimbursed under Medicare Part B. The law specifies that the federal Centers for Medicare & Medicaid Services (CMS) can begin enacting those price cuts in 2017.
- Laboratory benefit management program
The laboratory benefit management program is a controversial program created by UnitedHealthcare in 2014. All outpatient laboratory services for members who are part of the Laboratory Benefit Management Program are subject to new requirements including advance notification and new medical policies.
Physicians serving UHC’s commercial patients in Florida must notify UHC when ordering any of 80 clinical laboratory tests. Pre-authorization is also required for certain tests.
During its introduction phase, the program has generated widespread resistance from Florida physicians, who protest that it will cause unnecessary delays for patient treatment, and undue burdens for doctors ordering tests. In addition to problems with lab test pre-notification algorithms within the BeaconLBS system, other problems cited by physicians include the exclusion of all but 13 Florida labs from the BeaconLBS “laboratory of choice network.”
- Accountable care organizations
ACOs are the product of a provision in the Affordable Care Act of 2010. They are integrated care networks of providers with the ability to provide care to, and manage patients, across the continuum of care that should include different institutional settings, such as ambulatory care, inpatient hospital care, and even post-acute care. Clinical labs have had difficulty gaining entry into newly- forming ACOs.
At the same time, a positive clinical laboratory trend is the increasing popularity of personalized medicine (PM), a medical model that proposes the customization of healthcare – with medical decisions, practices, and/or products being tailored to the individual patient. In this model, diagnostic testing is critically important, as it is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis.
ASCP’s New Pathology Analytics Platform Aims to Improve Workflows
By Scott Wallask | From the Volume XXXIII, No. 10 – August 2026 Issue
CEO SUMMARY: During a recent webinar, Sachin Gupta, PhD, of the American Society for Clinical Pathology demonstrated the organization’s new Performance and Diagnostics Insights (PDI) analytics and benchmarking platform. PDI provides e…
How Clinical Lab Leaders Can Take Advantage of C-Suite Priorities
By Scott Wallask | From the Volume XXXIII, No. 10 – August 2026 Issue
CEO SUMMARY: A new industry survey by Siemens Healthineers indicates that hospital executives increasingly recognize medical laboratories as vital clinical assets. However, securing capital based on that good will require…
Labs Looking at Cash-Based Options Face Complexity
By Stephen Beale | From the Volume XXXIII, No. 10 – August 2026 Issue
Given all the challenges of dealing with payers, many clinical laboratories find themselves tempted by the idea of offering cash-based business lines such as direct-to-consumer (DTC) testing. The patient pays up front and undergoes the test, and the lab banks the…
Direct-to-Consumer Clinical Laboratory Testing is Booming
By Mark Terry | From the Volume XXXIII, No. 10 – August 2026 Issue
As part of the ongoing and expanding healthcare direct-to-consumer (DTC) wellness trend, DTC laboratory testing is on the rise. It is driven by increasing at-home care, effective and affordable telehealth approaches, and significantly more convenient sampling and…
Experts Explain Evolving Ransomware Attacks
By Oscelle Boye | From the Volume XXXIII, No. 10 – August 2026 Issue
CEO SUMMARY: Security industry reports suggest that ransomware attacks will only increase. Cybersecurity experts who have navigated high-profile ransomware incidents offer details on how modern criminal incursions happen in clinical laboratories, including early warning si…
Allina Will Join Sutter, Focus on Digital Growth
By Janette Wider | From the Volume XXXIII, No. 10 – August 2026 Issue
CEO SUMMARY: Minnesota-based Allina Health’s plans to join Sutter Health in California would create a multi-regional integrated delivery network backed by a $2 billion push into digital and outpatient care. As has been illustrated by past agreements and mergers, clinical…
Providers May Be Ordering Inappropriate Vitamin D Tests
By Stephen Beale | From the Volume XXXIII, No. 10 – August 2026 Issue
Heightened consumer interest has been driving demand for vitamin D testing in recent years. However, clinical laboratories should be aware that some providers could be ordering the wrong test to measure levels of the vitamin, in part due to the way that online or…
Patient-Driven Testing Spurs New Opportunities
By Janette Wider | From the Volume XXXIII, No. 10 – August 2026 Issue
CEO SUMMARY: Patient-driven diagnostic testing is creating both opportunities and challenges for clinical laboratories, as increased demand and evolving business models stretch the industry’s capacity and profitability. However, an industry veteran in commercial lab prod…
Top Stories in 2025 Played Out in Courts, Capitol Hill
By Janette Wider | From the Volume XXXIII, No. 10 – August 2026 Issue
CEO SUMMARY: The biggest story of the year for clinical laboratories came in a huge court victory, as a federal judge vacated the FDA’s final rule on laboratory developed tests. Labs breathed a sigh of relief after the court decision, as the FDA rule had promised to incr…
Oracle Hopes to Sway Market with New AI-Assisted EHR
By Jillia Schlingman | From the Volume XXXIII, No. 10 – August 2026 Issue
W hile it remains to be seen whether it truly pushes boundaries, Oracle Health got attention when recently announcing it had released an immersive, next-generation electronic health records (EHR) platform fueled by artificial intelligence (AI). The system is conv…
CURRENT ISSUE
Volume XXXIII, No. 10 – August 2026
In the August 2026 briefing, The Dark Report explains the relevance behind CMS potentially changing how it pays for “software as a medical service”. Other topics include a look into how health system executives view clinical labs, possible CLIA updates, and a 30/60/90-day approach to reducing reliance on traveling medical lab techs.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized